Henri Steenkamp
Analyst · B. Riley. Your line is open
Thank you, Chris. Slide 4 highlights our key performance metrics for the fiscal fourth quarter ended February 28, 2023. When adjusting for the incentive fee accrual related to net capital gains, adjusted NII of $11.6 million was up 27.0% from last quarter, and up 82.4% from last year's Q4. Adjusted NII per share was $0.98, up $0.21 from $0.77 per share last quarter, and up $0.45 from $0.53 per share last year. Across the three quarters shown on the slide, weighted average common shares outstanding were relatively unchanged. There was zero accretion or dilution due to share repurchases and DRIP issuances this quarter. Adjusted NII increased significantly as compared with last year, with the 70.3% increase in investment income resulting primarily from a 19.0% increase in AUM. The increase in the current coupon on non-CLO BDC investments from 9.5% to 12.1%, including both base rate and some spread increases, and an increase in other income that included $3.0 million dividend and redemption fee income generated from the Artemis Wax equity sale this quarter. This all was partially offset by increased base management fees and interest expense resulting from the various new notes and SBA debentures issued during the past year and quarter. The full benefit of higher rates on AUM is still not yet fully reflected in interest income. Sequential quarter changes reflect the same factors as year-over-year, with the increase in current coupon from 11.7% to 12.1%. Adjusted NII yield was 13.6%. This yield is up from 10.8% last quarter and 7.3% last year. For this fourth quarter, we experienced a net gain on investments of $9.9 million or $0.84 per weighted average share, resulting in a total increase in net assets from operations of $19.2 million or $1.62 per share. The $9.9 million net gain on investments was primarily comprised of $10.5 million in net unrealized appreciation on investments, offset by a $0.4 million loss on extinguishment of borrowings resulting from the repayment of $40.7 million of our SBIC I debentures, as we continue to wind down our first SBIC fund. The $10.5 million in net realized appreciation primarily reflects, first, the $7.4 million unrealized appreciation on the company's CLO and JV equity investments, reflecting the volatility in the broadly syndicated loan market as of quarter end. Two, the $0.9 million unrealized appreciation on each of the company's Procurement Partners and Vector Controls investments, and the $0.6 million and $0.5 million unrealized appreciation on the company's Altvia Midco and Axero Holdings Investments respectively, all primarily reflecting company performance. And three, approximately $0.2 million net unrealized appreciation across the remainder of the portfolio. Return on equity remains a very important indicator for us, performance indicator for us, which includes both realized and unrealized gains. Our return on equity was 7.2% for the last 12 months, beating the industry average of 0.6%. Total expenses for Q4, excluding interest and debt financing expenses, base management fees and incentive fees, and income and excise taxes was $2.3 million, as compared to $1.8 million for Q4 last year and $2.1 million for last quarter. This represented 0.9% of average total assets on an annualized basis, unchanged from 0.9% last year and slightly up from 0.8% last quarter. Also, we have again added the KPI Slides 29 through 32 in the appendix at the end of the presentation that shows our income statement and balance sheet metrics for the past nine quarters and the upward trends we have maintained. A particular note is Slide 32, highlighting how our net interest margin run rate has continued to increase and has more than quadrupled since Saratoga took over management of the BDC and also increased by 55% the last 12 months, while still not yet receiving the full period benefit of putting to work the significant amount of Q4 cash, nor the full impact of the current rising rate environment. Slide 5 highlights the same key performance metrics for the full 2023 fiscal year. And moving on to Slide 6, NAV was $347.0 million as of quarter end, an $11.2 million increase from last quarter and an $8.8 million decrease from the same quarter last year. This quarter, the main drivers were $10.5 million of net realized gains and unrealized appreciation and $9.6 million of net investment income, partially offset by $8.1 million of dividends declared. In addition, during Q4, $1.3 million of stock dividend distributions were made through the company's DRIP plan, offset by $1.2 million of shares repurchased at an average price of $25.19. NAV per share was $29.18 as of quarter end, down from $29.33 12 months ago and up from $28.25 last quarter. This chart also includes our historical NAV per share, which highlights this has increased 16 of the past 20 quarters. Over the long term, our net asset value has steadily increased since 2011, and this growth has been accretive as demonstrated by the consistent increase in NAV per share. We continue to benefit from our history of consistent realized and unrealized gains. On Slide 7, you will see a simple reconciliation of the major changes in NII and NAV per share on a sequential quarterly basis. Starting at the top, adjusted NII per share increased from $0.77 to $0.98 per share. Main drivers were a $0.05 increase in non-CLO net interest income from the partial impact of higher AUM and interest rates, and a $0.25 increase in other income, primarily from the Artemis Wax dividend and redemption fees received. The main offset was a $0.07 decrease due to excise taxes incurred for the 2022 calendar year. Moving on to the lower half of the slide, this reconciles the $0.93 NAV per share increase for the quarter. $0.81 of GAAP NII and $0.90 of net realized gains of unrealized appreciation was primarily offset by the $0.68 dividend paid in Q4. On Slide 8 you will see the same reconciliation, but now on a sequential annual basis. Starting at the top, adjusted NII per share increased from $2.24 per share last year to $2.85 per share this year. The primary drivers were $1.17 increase in non-CLO net interest income reflecting higher AUM and interest rates, offset mainly by a $0.23 decrease in CLO net interest income and a $0.31 decrease from higher base management fees. On the lower half of the slide, this reconciles the $0.15 NAV per share decrease for the year. $2.94 of GAAP NII was primarily offset by $0.65 of net realized gains and unrealized depreciation on investments and the $2.28 dividend paid during the year. There was a $0.06 net accretion from the share repurchases and DRIP plan issuances in fiscal 2023. Slide 9 outlines the dry powder available to us as of quarter end, which totaled $276.6 million. This was spread between our available cash, undrawn SBA debentures and undrawn secured credit facility. This quarter end level of available liquidity allows us to grow our assets by an additional 28% without the need for external financing, with $96.1 million of quarter end cash available and thus fully accretive to NII when deployed, and $148 million of available SBA debentures with its low cost pricing, also very accretive. In January, we also entered into the first amendment to the credit agreement within Encina Capital in order to achieve a number of important improvements to this agreement. First, we increased borrowings available from $50 million to $65 million. Second, we changed the underlying benchmark used to compute interest from LIBOR to Term SOFR for a one-month tenor plus a 10 bps credit spread adjustment and increased the applicable effective margin rate on borrowings from 4% to 4.25%. And importantly, we extended the revolving period to January 2026. As we've mentioned before, we've made a number of important additions to our available liquidity since year end. We have issued baby bonds totaling $77.5 million for net proceeds of $75.0 million, including a new $57.5 million, 8.5% 2028 public baby bond trading under the ticker SAZ. The net proceeds of these offerings are being used to repay a portion of outstanding undebtedness under the credit facility, make investments in middle market companies in accordance with our investment objective and strategies, including investments made through SBIC III and for general corporate purposes. We remain pleased with our available liquidity and leverage position, including our access to diverse sources of both public and private liquidity, and especially taking into account the overall conservative nature of our balance sheet. The fact that almost all our debt is long-term in nature, with almost no non-SBIC debt maturing within the next 2.5 years, and importantly that almost all our debt is fixed rate in this rising rate environment. Also, our debt is structured in such a way that we have no BDC covenants that can be stressed and with available call options in the next two years on the debt with higher coupons, important during such volatile times. Now, I would like to move on to Slides 10 through 14 and review the composition and yield of our investment portfolio. Slide 10 highlights that we now have $973 million of AUM at fair value or $966 million at cost, invested in 49 portfolio companies, one CLO fund and one joint venture. Our first lien percentage is 82% of our total investments, of which 26% is in first lien last out positions. On Slide 11, you can see how the yield on our core BDC assets, excluding our CLO has changed over time, especially the past quarter. After an extended period of low rates and tightening spreads, we are seeing both those trends reverse. We have already seen much benefit in Q3 and Q4 with our core BDC portfolio yield increasing to 12.1% from 9.5% last year and from 11.7% last quarter. Total yield has increased to 10.7% from 7.7% last year and 10.4% last quarter. But the full impact of the rising rate environment through today is still not yet reflected fully in our earnings. In addition, we are seeing spreads widening, with 99% of our interest-earning portfolio being variable rate, all of our investments being above their floors and rates continuing to rise since year end, we expect to benefit going forward from the earnings impact of rising rates to our NII, as you can see on the next slide. The CLO yield stayed unchanged at 7.4% versus last quarter, reflecting current market performance. The CLO is performing and current. Slide 12 shows how at the end of Q4, the average three month LIBOR used in our portfolio was 466 basis points versus at quarter end when three month LIBOR closed at 497 basis points and versus today at approximately 525. With 99% of our interest-earning assets using variable rates, earnings will benefit from this additional increase in Q1 and Q2, while all but $52.5 million of our quarter end borrowing is fixed rate and will not be impacted by these increases in base rates. The increase in SOFR base rates are similar. There is uncertainty about the future of rates, but we stand to continue to gain as rates rise. That said, there will be a lag in the effect of this dynamic has on our earnings due to timing of rate resets and invoicing terms. Slide 13 shows how our investments are diversified throughout the U.S. And on Slide 14 you can see the industry breadth and diversity that our portfolio represents. Our investments are spread over 38 distinct industries with a large focus on healthcare and education software, HVAC services and sales and IT, real estate, education, consumer and healthcare services, in addition to our investments in the CLO and JV, which are included as structured finance securities. Of our total investment portfolio, 10.0% now consists of equity interest, which remain an important part of our overall investment strategy. For the past 11 fiscal years, we had a combined $81.5 million of net realized gains from the sale of equity interest or sale or early redemption of other investments. And two-thirds of these historical total gains were fully accretive to NAV due to the unused capital loss carry-forwards that were carried over from when Saratoga took over management of the BDC. We continue to have a $1.6 million capital loss as of year-end for tax purposes. This consistent realized gain performance highlights our portfolio credit quality has helped grow our NAV and is reflected in our healthy long-term ROE. That concludes my financial and portfolio review. I will now turn the call over to Michael Grisius, our Chief Investment Officer, for an overview of the investment market.